Hanmi Science Co., Ltd.

KRX:008930.KS

33050 (KRW) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 1,247,906.3791,046,054.211950,164.817857,383.419816,618.824707,995.356652,324.368665,284.666776,215.271532,604.691219,862.56619,645.98916,812.303641,470.958689,962.982606,802.686531,396.197
Cost of Revenue 1,021,048.684944,352.143817,393.4736,667.633708,285.638615,585.388624,017.116637,606.169619,538.4791,493.2331,457.14600274,514.146269,849.833216,339.105174,550.028
Gross Profit 226,857.695101,702.068132,771.417120,715.787108,333.18692,409.96828,307.25227,678.497156,676.792531,111.458218,405.4219,645.98916,812.303366,956.812420,113.149390,463.581356,846.169
Gross Profit Ratio 0.1820.0970.140.1410.1330.1310.0430.0420.2020.9970.993110.5720.6090.6430.672
Reseach & Development Expenses 78800000000000060,837.44149,304.05434,668.95836,770.181
General & Administrative Expenses 38,534.815897,840.03410,882.3689,815.6299,319.44510,841.035572,134.922590,907.23569,587.923475,688.842171,124.5023,362.6923,225.20587,314.24386,590.11186,887.8569,963.115
Selling & Marketing Expenses 67,830.83857,155.69341,829.38737,725.45935,563.23628,322.05226,302.8524,559.8621,519.30917,878.05712,525.8252,622.3541,866.00288,000.94785,383.69966,381.41557,179.931
SG&A 169,057.779954,995.72752,711.75547,541.08944,882.68139,163.086598,437.772615,467.09591,107.232493,566.899183,650.3265,985.0455,091.207175,315.19171,973.81153,269.265127,143.046
Other Expenses 330.00662,946.94652,467.9749,326.30248,748.33943,702.671-4,154.236-10,185.81618,209.8783,299.86376.863991.0438,414.9071,148.1935,902.7411,400.61123.217
Operating Expenses 169,845.7791,017,942.673105,179.72596,867.39193,631.0282,865.757638,352.571650,217.355629,559.5523,593.17213,573.18316,031.70813,506.114362,840.934347,124.023308,770.321276,035.265
Operating Income 57,011.91667,626.01458,852.29132,502.30537,986.17726,155.01139,071.35128,651.638216,415.18617,470.78811,185.4664,147.5314,413.989,454.85972,989.12781,693.2680,810.904
Operating Income Ratio 0.0460.0650.0620.0380.0470.0370.060.0430.2790.0330.0510.2110.2630.0150.1060.1350.152
Total Other Income Expenses Net 6,072.9665,553.704-9,730.103-2,535.971-2,554.155-7,335.09719,426.3183,846.87987,075.1639,656.44,160.099,239.292629.076-10,573.534-10,571.00212,206.817-1,629.242
Income Before Tax 63,084.88273,179.71949,122.18829,966.33435,432.02218,819.91533,398.11518,914.19233,730.93518,667.92110,449.47312,853.5723,935.265-6,457.65662,418.12493,900.07779,181.662
Income Before Tax Ratio 0.0510.070.0520.0350.0430.0270.0510.0280.3010.0350.0480.6540.234-0.010.090.1550.149
Income Tax Expense 15,421.7894,144.3976,182.2657,369.734,689.144798.292,579.8610,973.88256,281.076-3,194.459851.581372.87318,621.419-7,343.3296,133.47418,597.17623,359.551
Net Income 115,121.51369,209.57942,941.99622,601.09630,741.64918,019.52630,068.9737,937.683178,520.88321,312.1649,578.32812,479.133-14,690.5065,977.01350,526.89471,551.23452,997.718
Net Income Ratio 0.0920.0660.0450.0260.0380.0250.0460.0120.230.040.0440.635-0.8740.0090.0730.1180.1
EPS 1,694.061,010.45625.8329.31456.81268.09450.15116.182,629.06307.54134.05174.16-222.62112.593,129.384,356.813,382.74
EPS Diluted 1,694.061,010.45625.8329.31456.81262.37450.15116.182,629.06307.54134.05174.16-222.62112.593,129.384,356.813,382.74
EBITDA 65,744.29684,591.23558,010.50438,429.7244,449.37725,692.54939,302.10823,496.281238,412.61923,004.5212,874.7815,168.925,706.54641,322.298124,361.14766,230.312102,524.652
EBITDA Ratio 0.0530.0810.0610.0450.0540.0360.060.0350.3070.0430.0590.7720.3390.0640.180.1090.193